Loading, please wait...
Microsoft Teams meeting
Meeting ID: 219 940 607 994 554 4
Passcode: Yd3hA3G8
Date: Dec 17, 2026 02:00 PM - 03:00 PM
Fee
$0.00
CE Hours
2.00
CE Units
0.200
Registration closes on Jan 01, 2027 11:00 PM
Activity Type
- Application
Target Audience(s)
- Pharmacists
- Pharmacy Technicians
Accreditation(s)
|
WellStar Health System is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
|
Requirements for CE Credit
Participants who attend the entire activity, complete and pass the post-test (>70%) and complete the activity evaluation will receive CE credit.
Credit will be uploaded electronically and be available in CPE Monitor after completion of required elements.
Support/Credits
No commerical support.
Thu, Dec 17, 2026
Thu, Dec 17, 2026
Microsoft Teams meeting
Meeting ID: 219 940 607 994 554 4
Passcode: Yd3hA3G8
Objectives
- Describe the mechanisms of action of finerenone, and GLP-1/GIP-based therapies used in HFpE
- Identify common adverse effects associated with these therapies, including hyperkalemia, hypotension, genitourinary infections, and gastrointestinal effects
- Identify key patient populations who may benefit from newer HFpEF therapies including patients with obesity or persistent symptoms despite standard therapy
Speaker(s)/Author(s)
|
Melissa Rossi, PharmD
|
Activity Number
0483-0000-26-010-L01-T
Date:
12/17/26
Time:
02:00 PM - 03:00 PM
CE Hours
1.00
Location
via MS Teams and KH
Microsoft Teams meeting
Meeting ID: 219 940 607 994 554 4
Passcode: Yd3hA3G8
Objectives
- Evaluate current evidence and guideline recommendations for the use of finerenone and GLP-1/GIP-based therapies in patients with HFpE
- Select appropriate HFpEF pharmacotherapy based on patient-specific factors, including ejection fraction, renal function, potassium, obesity, diabetes, and comorbid conditions
- Assess appropriate candidates for finerenone and GLP-1/GIP-based therapies based on current guideline recommendations and clinical trial evidence
Speaker(s)/Author(s)
|
Melissa Rossi, PharmD
|
Activity Number
0483-0000-26-010-L01-P
Date:
12/17/26
Time:
06:45 AM - 07:45 AM
CE Hours
1.00
Location
via MS Teams and KH